Back to PathoKing

ITP module

Immune Thrombocytopenia

Understand how antiplatelet immunity accelerates clearance and impairs production, causing isolated thrombocytopenia whose treatment follows bleeding risk rather than count alone.

intermediate32 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Immune Thrombocytopenia?

Different triggers converge on the condition's central pathological process.

Primary ITP

Typical setting: No associated disorder is identified after appropriate assessment.

Loss of immune tolerance produces platelet and megakaryocyte-directed antibodies and T-cell responses.

Viral infection

Typical setting: HIV, hepatitis C, and other infections can be associated.

Molecular mimicry, immune activation, altered production, and splenic effects create thrombocytopenia.

Autoimmune disease

Typical setting: SLE and antiphospholipid-associated disease may include immune platelet loss.

Systemic B- and T-cell dysregulation generates platelet-reactive immunity.

Lymphoid malignancy

Typical setting: CLL and lymphoma disrupt normal immune regulation.

Abnormal B-cell clones or secondary autoimmunity increase platelet clearance.

Immune deficiency

Typical setting: Common variable immune deficiency and related disorders can paradoxically cause autoimmunity.

Dysregulated antibody responses target platelets despite impaired protective immunity.

Drug-dependent immune thrombocytopenia

Typical setting: Quinine, selected antibiotics, and other medicines trigger abrupt severe falls.

Drug-dependent antibodies bind platelet epitopes in the presence of the medicine; stopping exposure is essential.

Helicobacter pylori association

Typical setting: A subset of patients improves after eradication in populations where the association is relevant.

Chronic antigenic stimulation and cross-reactive immunity may sustain platelet destruction.

Post-vaccination or childhood post-viral disease

Typical setting: An immune trigger precedes otherwise typical ITP.

Transient immune cross-reactivity often resolves more readily in children than chronic adult disease.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

Tolerance to platelet antigens fails

B cells, T cells, and antibodies target platelet glycoproteins or related structures.

2

Platelets become opsonised

IgG and immune signals mark circulating platelets for recognition.

Checking account access...